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BACKGROUND
Headache is one of the most common presenting complaints in patients attending primary care centers and the
majority of them have primary headache syndromes. Depressive disorders are among the leading causes of disability
globally and can further complicate the clinical manifestation if coupled with other comorbidities. Therefore, the
primary objective of our study was to determine the prevalence of depression in migraine patients presenting at a
tertiary care hospital to better understand the leading causes of the disease.
METHODS
A cross-sectional study was carried out between December 2019 and June 2020 (six months) including 66 migraine
patients between 18 and 45 years of age presenting to the neurology outpatient clinics at a tertiary care hospital in
Karachi, Pakistan. Non-probability convenience-based sampling technique was used to calculate the sample size, and
the data was collected via face-to-face interviews. The first section of the questionnaire consisted of
socio-demographic factors such as age, gender, educational, occupational, and marital status in addition to the clinical
characteristics such as the duration of the disease and the frequency of migraine attacks. The second section
assessed the depressive symptoms of the participants using the Patient Health Questionnaire-9 (PHQ-9) and any
patient with a score of five or more was considered as suffering from a depressive disorder. All statistical analysis was
conducted using Statistical Package for Social Sciences (SPSS) version 23.0.
RESULTS
Out of a total of 66 participants, almost two-third (n=43, 65.2%) were males, while nearly one-third (n=23, 34.9%)
were females. The average age of the patients was 27.59±5.37 years. The frequency of depression was observed in
approximately three-quarters (n=49, 74.2%) of the migraine patients in our study. The prevalence of depression was
only significantly associated with disease duration (p=0.027) and the number of migraine attacks (p=0.015).
CONCLUSION
In conclusion, the prevalence of depression was found to be significantly high among migraine patients, therefore
migraine might be related to depression. Depression should not be ignored while evaluating migraine subjects for good
prognosis and management of the disease.
KEYWORDS migraine, psychiatric disorders, depression
INTRODUCTION
Migraine is a chronic neurological disorder that is
characterized by pulsating headache (i.e. feeling of
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fullness over the forehead) that occurs in recurrent
attacks and is often unilateral [1]. It can be
accompanied by other clinical manifestations including
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duration at the neurology out-patient clinic of a tertiary
care hospital in Karachi, Pakistan.

nausea, vomiting, vertigo, photophobia, and
phonophobia (i.e. sensitivity of light and sound) [1, 2]. It is
classified as the third most common disease with an
estimated prevalence of 14.7% globally [3]. It is ranked
as the seventh most disabling disorder worldwide
responsible for 2.9% of all years of life lost to disability

Sample size, inclusion and exclusion criteria
Non-probability
convenience-based
sampling
technique was used to calculate the sample size of 66
patients. The sample population included all patients
between 18-45 years of age and either gender (i.e.
male or female) having a history of migraine headache
of two months’ duration. All patients were labeled as
having depression as per operational definition.
However, we excluded all individuals already taking
anti-depressant medications. We also excluded all
patients with major medical disorders including
diabetes, myocardial infarction, and hypertension (as
per medical record). Ethical approval was obtained
from the Institutional Review Board.

[1, 3].

Depression
comprises
symptoms
of
feeling
melancholic, lack of spirit, loss of enjoyment, changes
in appetite, sleep, and low energy resulting in increased
lethargy lasting for two weeks [4]. Clinically significant
depression is associated with low quality of life and has
been recognized as the major contributor to suicide and
disability burden globally by the World Health
Organization (WHO) [4, 5].
A bi-directional association seems to exist between
depression and migraine, with each disorder enhancing
the possibility of the other [6]. Published literature
suggests rates of psychiatric comorbidity to range
between 69% and 87% among migraine patients [7, 8].
The findings of a pooled meta-analyses reported that
depression is nearly two times more frequent in
subjects with migraine than in people unaffected by
headache [9]. Another study conducted in England
demonstrated a relationship between migraines and
affective disorders, particularly depression [10]. Lastly, a
study carried out in Taiwan demonstrated greater than
three-quarters (78%) of the population with
transformed migraine have psychiatric comorbidity with
more than half (57%) suffering from major depression [11].

SAMPLING TECHNIQUE AND DATA COLLECTION
All
data
were
collected
via
an
interviewer-administered-questionnaire. The principal
investigator explained the purpose and the
methodology of the study to all migraine patients.
Those migraine patients who agreed to participate were
also asked to give both verbal and written informed
consent before their inclusion in the study. A
well-standardized two-section questionnaire was
designed to collect data for this study. The first section
of the questionnaire was based on the participant's
socio-demographic characteristics including gender,
age, educational, occupational, monthly income, and
marital status in addition to the clinical factors such as
duration of the disease and the frequency of migraine
attacks. The second section consisted of questions
about the Patient Health Questionnaire-9 (PHQ-9) [12]
utilized to assess the frequency of depression among
migraine patients based on recommended duration
(two weeks) and scores mentioned as follows: mild
depression (a score of 5-9), moderate depression (a
score of 10-14), moderately severe (a score of 15-19)
and severe depression (a score of 20 or above).
Depressive disorder was labeled as positive for a score
of ≥5 otherwise it was labeled as negative. The
questionnaire was also reviewed by two senior
neurologists for validity and reliability (reliability index
0.85).

Psychiatric comorbidity such as depression complicates
the management of migraine patients and results in
poor prognosis. The mechanisms underlying migraine
are reported to be highly complex and a wide
heterogeneity exists with a proportion of the population
being fully functional while others experiencing serious
disabilities such as encountering social, affective, and
occupational limitations. Much of this heterogeneity is
accounted for by the presence of comorbidities
including psychiatric illnesses [9]. Hence, the primary
objective of this study was to determine the frequency
of depression in migraine patients presenting to the
neurology department in our part hospital. A secondary
aim was to determine the impact of socio-demographic
and clinical factors on the observed depression
prevalence in migraine patients.

STATISTICAL ANALYSIS
All statistical analysis was performed using Statistical
Package for Social Sciences (SPSS) version 23.0.
Frequencies and percentages were computed for
categorical variables like sex, marital status, education
status, occupation status, monthly income, and
depression. Mean and standard deviations were

METHODS
STUDY SETTING AND DESIGN
This was a cross-sectional study conducted between
December 2019 and June 2020. Over six months’
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computed for continuous variables like age and
duration of illness. Effect modifiers like age, sex,
duration of illness, marital status, education status,
occupational status, and socioeconomic status were
controlled through stratification by applying Chi-square
and Fischer's exact test. A p-value of≤0.05 was
considered statistically significant.
RESULTS
SOCIO-DEMOGRAPHIC AND CLINICAL
CHARACTERISTICS OF THE PARTICIPANTS
A total of 66 migraine patients participated in this
study. The mean age of the patients was 27.59±5.37
years. The median duration of the migraine disease in
our sample population was two [interquartile range
(IQR)=1] months while the median number of migraine
attacks was 3 (IQR=1).
Nearly three-fifth (n=39, 59.1%) of our sample
population were males while (n=27, 40.9%) were
females. Nearly two-third (n=43, 65.2%) of patients
were married while (n=23, 34.8%) were unmarried.
The highest proportion of migraine patients in our study
were graduates (n=26, 39.4%) followed by (n=11,
16.7%) in intermediate level, while equal proportions of
our participants were not formally educated and
received secondary degrees (n=8, 12.1%). Equal
proportions received primary and master degrees
(n=6, 9.1%). The highest proportion of participants in
our survey were privately employed (n=30, 45.5%)
followed by government employees (n=13, 19.7%)
and industrial workers (n=14, 21.2%). Half of the
patients (n=33, 50.0%) earned a monthly income of
less than 30,000 rupees, followed by (n=31, 46.9%)
earned between 31,000 and 70,000 rupees, while a
very minor proportion (n=2, 3.03%) earned greater
than 70,000 rupees (Table 1).

Table 1: Sociodemographic characteristics of the
participants
Prevalence of depression among the participants
and its association with socio-demographic and
clinical factors
Nearly three-quarters (n=49, 74.2%) of our
participants were suffering from depression as
determined using the PHQ-9 questionnaire, as
illustrated in Figure 1.

Figure 1: Prevalence of depression in migraine
patients
The highest prevalence of depression (n=28, 57.1%)
was observed in patients aged 26-30 years, however,
this did not reach statistical significance (p=0.708).
Depression was more common in male patients
(n=27, 55.1%) in comparison to females (n=22,
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the migraine burden is contributed by the coexisting set
of psychiatric disorders namely depression, anxiety,
phobias, and panic attacks. Breslau and his colleagues
in their study demonstrated this relationship between
migraine and depression by reporting a three-fold
increased risk of depression in migraine patients
compared to non-migraine ones while those who had
depression without a previous history of migraine were
also three times more likely to develop migraine
compared with non-depressed patients

44.9%), however, the difference was not statistically
significant (p=0.263). Furthermore, depression was
not significantly associated with the marital status of
the patients (p=0.525).
In contrast, depression was significantly associated
with the disease duration (p=0.027) as nearly
three-quarters (n=37, 75.5%) of the depressed
participants had a disease duration of two to three
months while only a quarter (n=12, 24.5%) of
migraine patients that had depression reported a
disease duration of greater than three months.
Depression was also significantly associated with the
number of migraine attacks (p=0.015) as a greater
proportion (n=36, 73.5%) of patients that had
depression experienced two to three migraine attacks
in comparison to those with four to five migraine
attacks (n=13, 26.5%) (Table 2).

Studying the relationship between migraine and
depression is essential for diagnosis and management.
This cross-sectional study comprised 66 patients
presenting with migraine headaches with a mean age
of 27.59±5.37 years with most of the patients
between 26 and 30 years of age. The onset of migraine
occurs from childhood being more prevalent between
20-30 years and declining after 40 years of age.
Hence, the prevalence increases from the first to fourth
decades and declines thereafter [16]. Migraines are
reported to be precipitated by multiple environmental
and genetic factors with nearly two-thirds of cases
having a familial association [17]. Additionally, women
are three times more susceptible to migraine attacks
compared to men and this difference is reported to be
hormonally-driven [18, 19]. Nearly 18% of women and 6%
of men suffer a migraine annually, with a lifetime risk of
43% and 18% respectively in the United States [17]. In
Europe, 12-28% of people get affected by migraine
once in their lifetime with about 14-35% of adult
women and 6-15% of adult men getting at least once
yearly [18]. However, in our study, 59.1% of males and
40.9% of females reported migraine headaches. Our
study reported higher migraine prevalence because it
was conducted in a developing country with a
significant percentage of the population living below
poverty with greater depression rates.
[15].

Migraine significantly affects the functional capacity of
an individual making most of the daily tasks impossible
to perform. Published literature reports that migraine is
also negatively associated with years of schooling and
grades. Migraine makes it difficult to maintain regular
attendance and concentrate on studies. Students with
migraine headaches are often forced to miss school
and even if they attend school, their productivity is
remarkably reduced. It increases the cost of remaining
in school to the extent that it hinders learning, it can be
considered as reducing the returns to remain in school

Table 2: Association of socio-demographic and
clinical characteristics with a prevalence of
depression in migraine patients
DISCUSSION
Our results report a high prevalence of depression
amongst patients with Migraines. These migraine
attacks are also reported to be associated with nausea
and changes in vision. This neurological disorder affects
the quality of life (QOL) of an individual and results in
significant loss of productivity [13, 14]. The proportion of
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Our study provides the hindsight that depression is as
common among migraine sufferers as patients
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into account when formulating an effective treatment
plan. Treatment of one disorder can prevent further
progression to one or both of them and result in a good
prognosis. A suitable therapeutic approach among
migraine subjects can reduce the disability burden
among these subjects, hence reducing health-care
resources and economic burden.

suffering from other chronic diseases. The frequency of
depression among migraine subjects was observed to
be 74.2%. Wang et al in a study comprising subjects
over 65 years reported that the risk of current
depression was greater in migraine than in
non-migraine patients [22]. Merikangas et al. in their
study comprising 457 younger subjects reported an
increased risk of developing major depression and
anxiety disorders compared with controls [23]. A
population-based case-control study conducted by
Lipton et al. confirmed a higher risk of current
depression among patients suffering from migraines
[14]. Swartz et al. studied psychiatric illnesses as
possible risk factors for migraine onset with a
prospective follow-up of 13 years and demonstrated
that only a history of phobic disorder predicted migraine
onset [24].
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